Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation
- PMID: 15572109
- DOI: 10.1016/j.neuron.2004.11.023
Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation
Abstract
A concept in Parkinson's disease postulates that motor cortex may pattern abnormal rhythmic activities in the basal ganglia, underlying the genesis of observed motor symptoms. We conducted a preclinical study of electrical interference in the primary motor cortex using a chronic MPTP primate model in which dopamine depletion was progressive and regularly documented using 18F-DOPA positron tomography. High-frequency motor cortex stimulation significantly reduced akinesia and bradykinesia. This behavioral benefit was associated with an increased metabolic activity in the supplementary motor area as assessed with 18-F-deoxyglucose PET, a normalization of mean firing rate in the internal globus pallidus (GPi) and the subthalamic nucleus (STN), and a reduction of synchronized oscillatory neuronal activities in these two structures. Motor cortex stimulation is a simple and safe procedure to modulate subthalamo-pallido-cortical loop and alleviate parkinsonian symptoms without requiring deep brain stereotactic surgery.
Similar articles
-
Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.Brain. 2004 Feb;127(Pt 2):408-19. doi: 10.1093/brain/awh053. Epub 2003 Dec 22. Brain. 2004. PMID: 14691060
-
Subthalamo-pallidal interactions underlying parkinsonian neuronal oscillations in the primate basal ganglia.Eur J Neurosci. 2011 Nov;34(9):1470-84. doi: 10.1111/j.1460-9568.2011.07865.x. Eur J Neurosci. 2011. PMID: 22034978
-
Parkinsonism and vigilance: alteration in neural oscillatory activity and phase-amplitude coupling in the basal ganglia and motor cortex.J Neurophysiol. 2017 Nov 1;118(5):2654-2669. doi: 10.1152/jn.00388.2017. Epub 2017 Aug 23. J Neurophysiol. 2017. PMID: 28835526 Free PMC article.
-
Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder.Ann N Y Acad Sci. 2003 Jun;991:199-213. doi: 10.1111/j.1749-6632.2003.tb07477.x. Ann N Y Acad Sci. 2003. PMID: 12846988 Review.
-
Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.Mov Disord. 2008;23 Suppl 3:S548-59. doi: 10.1002/mds.22062. Mov Disord. 2008. PMID: 18781672 Review.
Cited by
-
Dysfunction of motor cortices in Parkinson's disease.Cereb Cortex. 2024 Jul 3;34(7):bhae294. doi: 10.1093/cercor/bhae294. Cereb Cortex. 2024. PMID: 39066504 Free PMC article. Review.
-
Clinical neurophysiology in the treatment of movement disorders: IFCN handbook chapter.Clin Neurophysiol. 2024 Aug;164:57-99. doi: 10.1016/j.clinph.2024.05.007. Epub 2024 May 23. Clin Neurophysiol. 2024. PMID: 38852434 Review.
-
A model description of beta oscillations in the external globus pallidus.Cogn Neurodyn. 2023 Apr;17(2):477-487. doi: 10.1007/s11571-022-09827-w. Epub 2022 Jun 21. Cogn Neurodyn. 2023. PMID: 37007193 Free PMC article.
-
Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson's Disease: A Perspective Through Preclinical and Clinical Evidence.Front Pharmacol. 2022 Apr 7;13:805388. doi: 10.3389/fphar.2022.805388. eCollection 2022. Front Pharmacol. 2022. PMID: 35462934 Free PMC article. Review.
-
Deep brain stimulation of the thalamus restores signatures of consciousness in a nonhuman primate model.Sci Adv. 2022 Mar 18;8(11):eabl5547. doi: 10.1126/sciadv.abl5547. Epub 2022 Mar 18. Sci Adv. 2022. PMID: 35302854 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
